Ben Wylie

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Venues

Oncoimmunology

Cancers

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Francois Xavier Rwandamuriye, Tao Wang, Hanfu Zhang, Omar Elaskalani, Jorren Kuster, Xueting Ye, Breana Vitali, Juliët Schreurs, M Lizeth Orozco Morales, Marck Norret, Cameron W Evans, Rachael M Zemek, K Swaminathan Iyer, W Joost Lesterhuis, Ben Wylie
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade. Oncoimmunology 13 (1) (2024)
Francois Xavier Rwandamuriye, Tao Wang, Hanfu Zhang, Omar Elaskalani, Jorren Kuster, Xueting Ye, Breana Vitali, Juliët Schreurs, M Lizeth Orozco Morales, Marck Norret, Cameron W Evans, Rachael M Zemek, K Swaminathan Iyer, W Joost Lesterhuis, Ben Wylie
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade. Oncoimmunology 13 (1) (2024)
Rachael M Zemek, Wee Loong Chin, Vanessa S Fear, Ben Wylie, Thomas H Casey, Cath Forbes, Caitlin M Tilsed, Louis Boon, Belinda B Guo, Anthony Bosco, Alistair R R Forrest, Michael J Millward, Anna K Nowak, Richard A Lake, Timo Lassmann, Willem Joost Lesterhuis
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice. Nature communications 13 (1) (2022)
Ben Wylie, Ferrer Ong, Hanane Belhoul-Fakir, Kristin Priebatsch, Heique Bogdawa, Anja Stirnweiss, Paul Watt, Paula Cunningham, Shane R Stone, Jason Waithman
Targeting Cross-Presentation as a Route to Improve the Efficiency of Peptide-Based Cancer Vaccines. Cancers 13 (24) (2021)

Ben Wylie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ben Wylie